The second aim was to compare the SPECT/CT tumour imaging data with the data concerning HER2 expression obtained by immunohistochemistry (IHC) and/or fluorescent in situ hybridization (FISH) analysis of biopsy samples.” The gene discussed is ERBB2; the disease is neoplasm.